Prolyl Oligopeptidase, Inositol Phosphate Signalling and Lithium Sensitivity

Author(s): Adrian J. Harwood

Journal Name: CNS & Neurological Disorders - Drug Targets
Formerly Current Drug Targets - CNS & Neurological Disorders

Volume 10 , Issue 3 , 2011

Become EABM
Become Reviewer
Call for Editor


Inhibition of prolyl oligopeptidase (PO) elevates inositol phosphate (IP) signalling and reduces cell sensitivity to lithium (Li+). This review discusses recent evidence that shows PO acts via the multiple inositol polyphosphate phosphatase (MIPP) to regulate gene expression. As a consequence, PO inhibition causes both a transient, rapid increase in I(1,4,5)P3 and a long-term elevation of IP signalling. This pathway is evolutionary conserved, being present in both the social amoeba Dictyostelium and human cell systems, and has potential implications for mental health.

Keywords: Bipolar mood disorder, Dictyostelium, inositol phosphate signalling, lithium, multiple inositol polyphosphate phosphatase, prolyl oligopeptidase, IMPase, LY294002, GSK-3, MIPP, ISYNA1

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [333 - 339]
Pages: 7
DOI: 10.2174/187152711794653779

Article Metrics

PDF: 34